How many drugs treat Anemia due to chemotherapy?

Drug Landscape tracks 5 marketed treatments for Anemia due to chemotherapy (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/anemia-due-to-chemotherapy.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Anemia due to chemotherapy — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anemia due to chemotherapy (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Anemia due to chemotherapy, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Epogen	EPOETIN ALFA	Amgen	Erythropoiesis-stimulating Agent	Erythropoietin receptor	1989-01-01
Epogen	Epoetin Alfa-Epbx	Amgen	Erythropoiesis-stimulating agent (ESA)	Erythropoietin receptor	1989-01-01
Erythropoietin	Erythropoietin	Nanjing First Hospital, Nanjing Medical University		Erythropoietin receptor
Epogen	Epogen	Johns Hopkins University		Erythropoietin receptor
Procrit	Procrit	University of Louisville		Erythropoietin receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Amgen · 2 drugs in Anemia due to chemotherapy
· 1 drug in Anemia due to chemotherapy
Johns Hopkins University · 1 drug in Anemia due to chemotherapy
Nanjing First Hospital, Nanjing Medical University · 1 drug in Anemia due to chemotherapy
University of Louisville · 1 drug in Anemia due to chemotherapy

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Anemia due to chemotherapy:

Cite this brief

Drug Landscape (2026). Anemia due to chemotherapy — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/anemia-due-to-chemotherapy. Accessed 2026-06-10.

Anemia due to chemotherapy full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing